- 专利标题: Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
-
申请号: US14279085申请日: 2014-05-15
-
公开(公告)号: US09624520B2公开(公告)日: 2017-04-18
- 发明人: Bernhard Geierstanger , Weijia Ou , Susan E. Cellitti , Tetsuo Uno , Tiffany Crossgrove , Hsien-Po Chiu , Jan Grunewald , Xueshi Hao
- 申请人: Bernhard Geierstanger , Weijia Ou , Susan E. Cellitti , Tetsuo Uno , Tiffany Crossgrove , Hsien-Po Chiu , Jan Grunewald , Xueshi Hao
- 申请人地址: CH Basel
- 专利权人: Novartis AG
- 当前专利权人: Novartis AG
- 当前专利权人地址: CH Basel
- 代理机构: Genomics Institute of the Novartis Research Foundation
- 代理商 Daniel E. Raymond
- 主分类号: C07C229/28
- IPC分类号: C07C229/28 ; C07C247/12 ; C07C323/25 ; C12P21/00 ; C07D207/20 ; C07D207/48 ; C07K5/02
摘要:
Disclosed herein is pyrroline-carboxy-lysine (PCL), a pyrrolysine analog, which is a natural, biosynthetically generated amino acid, and methods for biosynthetically generating PCL. Also disclosed herein are proteins, polypeptides and peptides that have PCL incorporated therein and methods for incorporating PCL into such proteins, polypeptides and peptides. Also disclosed herein is the site-specific derivatization of proteins, polypeptides and peptides having PCL or pyrrolysine incorporated therein. Also disclosed herein is the crosslinking of proteins, polypeptides and peptides having PCL or pyrrolysine incorporated therein.
公开/授权文献
信息查询